RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 82 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $493,000 | +6.5% | 21,459 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $463,000 | -6.7% | 21,459 | -4.9% | 0.00% | 0.0% |
Q2 2019 | $496,000 | -2.9% | 22,559 | +20.9% | 0.00% | 0.0% |
Q1 2019 | $511,000 | +23.7% | 18,659 | +21.5% | 0.00% | 0.0% |
Q4 2018 | $413,000 | -2.8% | 15,359 | +5.5% | 0.00% | 0.0% |
Q3 2018 | $425,000 | +16.8% | 14,562 | +24.9% | 0.00% | 0.0% |
Q2 2018 | $364,000 | – | 11,659 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP, LLC | 2,981,437 | $86,969,000 | 72.32% |
MPM ASSET MANAGEMENT LLC | 3,074,893 | $89,695,000 | 60.73% |
Foresite Capital Management IV, LLC | 696,903 | $20,329,000 | 6.66% |
NEA Management Company, LLC | 4,912,306 | $143,292,000 | 6.18% |
RA Capital Management | 1,950,332 | $56,891,000 | 3.04% |
Trustees of Princeton University | 47,643 | $1,390,000 | 1.96% |
Greylock XII GP LLC | 54,749 | $1,597,000 | 1.12% |
Baker Brothers Advisors | 2,708,200 | $78,998,000 | 0.52% |
Perceptive Advisors | 664,186 | $19,374,000 | 0.52% |
Sofinnova Investments, Inc. | 159,302 | $4,646,000 | 0.41% |